Involvement of RB gene family in tumor angiogenesis

Oncogene

Volumn 25, Issue 38, 2006, Pages 5326-5332

  Gabellini, C ^a   Del Bufalo, D ^a   Zupi, G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Angiogenesis; Cancer; Retinoblastoma family proteins

Indexed keywords

ANGIOGENESIS INHIBITOR; CAPSAICIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIN DEPENDENT KINASE 4; DNA; ENDOSTATIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FUMAGILLOL CHLOROACETYLCARBAMATE; HYPOXIA INDUCIBLE FACTOR 1; INDOMETACIN; INHIBITOR OF DIFFERENTIATION 2; INTERFERON; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN P107; PROTEIN P130; RAF PROTEIN; RETINOBLASTOMA PROTEIN; ROSIGLITAZONE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CELL MOTILITY; DNA SYNTHESIS INHIBITION; ENDOTHELIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; REVIEW; STRUCTURAL HOMOLOGY; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

ANGIOGENESIS INDUCING AGENTS; GENES, RETINOBLASTOMA; HUMANS; MULTIGENE FAMILY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RETINAL NEOPLASMS; RETINOBLASTOMA; TRANSCRIPTION FACTORS;

HUMAN PAPILLOMAVIRUS;

EID: 33748039091     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209631     Document Type: Review

References (110)

1. Abe J, Zhou W, Takuwa N, Taguchi J, Kurokawa K, Kumada M et al (1994). Cancer Res 54: 407-412.
2. Albert DM, Tapper D, Robinson NL, Felman R. (1984). Retina 4: 189-194.
3. Amellem O, Stokke T, Sandvik JA, Pettersen EO. (1996). Exp Cell Res 227: 106-115.
4. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL et al. (2002). Proc Natl Acad Sci USA 99: 7734-7739.
5. Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, Danenberg PV et al. (2000). Cancer Res 60: 2365-2367.
6. Bardos JI, Ashcroft M. (2005). Biochim Biophys Acta 1755: 107-120.
7. Beck Jr L, D'Amore PA. (1997). FASEB J 11: 365-373.
8. Beischlag TV, Taylor RT, Rose DW, Yoon D, Chen Y et al. (2004). J Biol Chem 279: 54620-54628.
9. Bergers G, Benjamin LE. (2003). Nat Rev Cancer 3: 401-410.
10. Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G et al. (2000). FASEB J 14: 652-660.
11. Budde A, Schneiderhan-Marra N, Petersen G, Brune B. (2005). Oncogene 24: 1802-1808.
12. Carmeliet P, Collen D. (2000). Ann NY Acad Sci 902: 249-262.
13. Castano E, Kleyner Y, Dynlacht BD. (1998). Mol Cell Biol 18: 5380-5391.
14. Chang KH, Chen Y, Chen TT, Chou WH, Chen PL, Ma YY et al. (1997). Proc Natl Acad Sci USA 94: 9040-9045.
15. Classon M, Dyson N. (2001). Exp Cell Res 264: 135-147.
16. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G et al. (1994). Cancer Res 54: 5556-5560.
17. Claudio PP, Howard CM, Pacilio C, Cinti C, Romano G, Minimo C et al. (2000). Cancer Res 60: 372-382.
18. Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S et al. (2004). Clin Cancer Res 10: 3509-3517.
19. Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM et al. (2001). Cancer Res 61: 462-468.
20. Dameron KM, Volpert OV, Tainsky MA, Bouck N. (1994). Science 265: 1582-1584.
21. Danielsen T, Hvidsten M, Stokke T, Solberg K, Rofstad EK. (1998). Br J Cancer 78: 1547-1558.
22. Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J et al. (2004). Mol Cell Biol 24: 9527-9541.
23. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP et al. (1997). J Biol Chem 272: 20971-20974.
24. Del Bufalo D, Biroccio A, Leonetti C, Zupi G. (1997). FASEB J 11: 947-953.
25. Dhanabal M, Volk R, Ramchandran R, Simons M, Sukhatme VP. (1999). Biochem Biophys Res Commun 258: 345-352.
26. Dyson N. (1998). Genes Dev 12: 2245-2262.
27. Farinelle S, Malonne H, Chaboteaux C, Decaestecker C, Dedecker R, Gras T et al. (2000). J Pharmacol Toxicol Methods 43: 15-24.
28. Fels DR, Koumenis C. (2005). Trends Biochem Sci 30: 426-429.
29. Ferrara N. (2000). Recent Prog Horm Res 55: 15-35.
30. Folkman J. (1995). Nat Med 1: 27-31.
31. Folkman J. (2003). Curr Mol Med 3: 643-651.
32. Gohji K, Fidler IJ, Tsan R, Radinsky R, von Eschenbach AC, Tsuruo T et al. (1994). Int J Cancer 58: 380-384.
33. Grana X, Garriga J, Mayol X. (1998). Oncogene 17: 3365-3383.
34. Hanahan D. (1997). Science 77: 48-50.
35. Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B et al. (2002). J Biol Chem 277: 16464-16469.
36. Harada H, Nakagawa K, Saito M, Kohno S, Nagato S, Furukawa K et al. (2003). Cancer Lett 191: 109-119.
37. Harbour JW, Dean DC. (2000a). Genes Dev 14: 2393-2409.
38. Harbour JW, Dean DC. (2000b). Curr Opin Cell Biol 12: 685-689.
39. Heffelfinger SC, Yassin R, Miller MA, Lower EE. (2000). Pathobiology 68: 129-136.
40. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR et al. (2002). Cell 109: 625-637.
41. Howard CM, Claudio PP, De Luca A, Stiegler P, Jori FP, Safdar NM et al. (2000). Cancer Res 60: 2737-2744.
42. Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW et al. (1998). J Natl Cancer Inst 90: 1451-1460.
43. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. (1994). Genes Dev 8: 1270-1284.
44. Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G et al. (2002). FASEB J 16: 1453-1455.
45. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H et al. (1990). Nature 348: 555-557.
46. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. (2002). Proc Natl Acad Sci USA 99: 11946-11950.
47. Jin KL, Mao XO, Greenberg DA. (2000). Proc Natl Acad Sci USA 97: 10242-10247.
48. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ et al. (1999). Nat Med 5: 1418-1423.
49. Joshi B, Ordonez-Ercan D, Dasgupta P, Chellappan S. (2005). Oncogene 24: 2204-2217.
50. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B et al. (2001). Mol Cell 7: 811-822.
51. Kato N, Nawa A, Tamakoshi K, Kikkawa F, Suganuma N, Okamoto T et al. (1995). Am J Obstet Gynecol 172: 601-606.
52. Kerbel R, Folkman J. (2002). Nat Rev Cancer 2: 727-739.
53. Kerbel RS. (2000). Carcinogenesis 21: 505-515.
54. Krtolica A, Ludlow JW. (1996). Cancer Res 56: 1168-1173.
55. Kvanta A, Steen B, Seregard S. (1996). Exp Eye Res 63: 511-518.
56. Lacy S, Whyte P. (1997). Oncogene 14: 2395-2406.
57. Lasorella A, Rothschild G, Yokota Y, Russell Rg, Iavarone A. (2005). Mol Cell Biol 25: 3563-3574.
58. Le Buanec H, D'Anna R, Lachgar A, Zagury JF, Bernard J, Ittele D et al. (1999). Biomed Pharmacother 53: 424-431.
59. Li J, Hu SX, Perng GS, Zhou Y, Xu K, Zhang C et al. (1996). Oncogene 13: 2379-2386.
60. Li W, He Z, Li Y, Yanoff M. (2000). Microvasc Res 59: 286-289.
61. Ludlow JW, Howell RL, Smith HC. (1993). Oncogene 8: 331-339.
62. Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S et al. (2004). Lung Cancer 46: 77-85.
63. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L et al. (2001). Nat Med 7: 1194-1201.
64. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R et al. (1999). Nature 401: 670-677.
65. Madigan MC, Penfold PL. (1997). Ultrastruct Pathol 21: 95-107.
66. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C et al. (1997). Science 277: 55-60.
67. Min JK, Han KY, Kim EC, Kim YM, Lee SW, Kim OH et al. (2004). Cancer Res 64: 644-651.
68. Mittnacht S. (1998). Curr Opin Genet Dev 8: 21-27.
69. Miyashita H, Sato Y. (2005). Endothelium 12: 163-170.
70. Mulligan G, Jacks T. (1998). Trends Genet 14: 223-229.
71. Munger K, Howley PM. (2002). Virus Res 89: 213-228.
72. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D et al. (2001). Nature 412: 561-565.
73. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al. (1997). Cell 88: 277-285.
74. Pai R, Szabo IL, Kawanaka H, Soreghan BA, Jones MK, Tarnawski AS. (2000). Mol Cell Biol Res Commun 4: 111-116.
75. Pedram A, Razandi M, Hu RM, Levin ER. (1998). J Biol Chem 273: 13966-13972.
76. Pedram A, Razandi M, Levin ER. (2001). Endocrinology 142: 1578-1586.
77. Pepper MS, Montesano R, Orci L, Vassalli JD. (1991). Biochem Biophys Res Commun 176: 633-638.
78. Raffaella R, Gioia D, De Andrea M, Cappello P, Giovarelli M, Marconi P et al. (2004). Exp Cell Res 293: 331-345.
79. Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J et al. (2000). Cancer Res 60: 490-498.
80. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q et al. (2000). Genes Dev 14: 34-44.
81. Sanseverino F, Santopietro R, Torricelli M, D'Andrilli G, Russo G, Cevenini G et al. (2006). Cancer Biol Ther 5: 84-88.
82. Semenza GL. (2001). Curr Opin Cell Biol 13: 167-171.
83. Sherif ZA, Nakai S, Pirollo KF, Rait A, Chang EH. (2001). Cancer Gene Ther 8: 771-782.
84. Sheu WH, Ou HC, Chou FP, Lin TM, Yang CH. (2006). Life Sci 78: 1520-1528.
85. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ. (1995). Proc Natl Acad Sci USA 92: 4562-4566.
86. Singh RK, Gutman M, Llansa N, Fidler IJ. (1996). J Interferon Cytokine Res 16: 577-584.
87. Sondell M, Lundborg G, Kanje M. (1999). J Neurosci 19: 5731-5740.
88. Sondell M, Sundler F, Kanje M. (2000). Eur J Neurosci 12: 4243-4254.
89. Stanelle J, Stiewe T, Theseling CC, Peter M, Putzer BM. (2002). Nucleic Acids Res 30: 1859-1867.
90. Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K, Leitges M et al. (2002). Proc Natl Acad Sci USA 99: 721-726.
91. Taipale J, Keski-Oja J. (1997). FASEB J 11: 51-59.
92. Tashiro E, Maruki H, Minato Y, Doki Y, Weinstein IB, Imoto M. (2003). Cancer Res 63: 424-431.
93. Toma JG, El-Bizri H, Barnabe-Heider F, Aloyz R, Miller FD. (2000). J Neurosci 20: 7648-7656.
94. Tonini T, Rossi F, Claudio PP. (2003). Oncogene 22: 6549-6556.
95. Toussaint-Smith E, Donner DB, Roman A. (2004). Oncogene 23: 2988-2995.
96. Trimarchi JM, Lees JA. (2002). Nat Rev Mol Cell Biol 3: 11-20.
97. Trisciuoglio D, Iervolino A, Zupi G, Del Bufalo D. (2005). Mol Biol Cell 16: 4153-4162.
98. Udagawa T, Fernandez A, Achilles EG, Folkman J, D'Amato RJ. (2002). FASEB J 16: 1361-1370.
99. Vidal A, Zacharoulis S, Guo W, Shaffer D, Giancotti F, Bramley AH et al. (2005). Proc Natl Acad Sci USA 102: 6890-6895.
100. Wang S, Ghosh RN, Chellappan SP. (1998). Mol Cell Biol 18: 7487-7498.
101. Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA. (2003). Cancer Cell 3: 219-231.
102. Wegiel B, Bjartell A, Ekberg J, Gadaleanu V, Brunhoff C, Persson JL. (2005). Oncogene 24: 6385-6393.
103. Weinberg RA. (1995). Cell 81: 323-330.
104. Woo MS, Sanchez I, Dynlacht BD. (1997). Mol Cell Biol 17: 3566-3579.
105. Yu J, Tian S, Metheny-Barlow L, Chew LJ, Hayes AJ, Pan H et al. (2001). Circ Res 89: 1161-1167.
106. Zhai Y, Yu J, Iruela-Arispe L, Huang WQ, Wang Z, Hayes AJ et al. (1999). Int J Cancer 82: 131-136.
107. Zhang H, Shepherd AT, Eason DD, Wei S, Diaz JI, Djeu JY et al. (1999). Cell Growth Differ 10: 457-465.
108. Zhang SY, Liu SC, Johnson DG, Klein-Szanto AJ. (2000). Cancer Res 60: 5972-5976.
109. Zhu Y, Jin K, Mao XO, Greenberg DA. (2003). FASEB J 17: 186-193.
110. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW et al. (2000). J Biol Chem 275: 6051-6054.